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Abstract
Recent studies have shown that the lactating mammary gland is able to utilize plasma-derived dipeptides for milk protein
synthesis. However, it was not clear whether the peptides were hydrolysed followed by uptake of the constituent amino acids
or were taken up intact. In view of this, we have designed experiments to investigate (a) whether the lactating rat mammary
gland is capable of transporting hydrolysis-resistant dipeptides and (b) whether or not mammary cells are able to hydrolyse
peptides, including glutathione, extracellularly. The uptake of the hydrolysis-resistant dipeptides D-[3H]Phe-L-Gln and D-
[3H]Phe-L-Glu by the perfused rat mammary gland was low. Concomitant addition of L-Leu-L-Ala (50 mM) had no effect on
the clearance of either labelled dipeptide suggesting that the small, albeit significant, uptake of the dipeptides is not via a high
affinity peptide transporter (PepT1/PepT2). All anionic dipeptides tested (L-Glu-L-Ala, L-Asp-L-Ala, L-Ala-L-Asp, L-Asp-
Gly, Gly-L-Asp and Gly-L-Glu) with the exception of D-Phe-L-Glu were able to trans-accelerate the efflux of labelled D-
aspartate from preloaded rat mammary tissue (explants and perfused mammary gland). It appears that these peptides were
being hydrolysed extracellularly followed by the uptake of free anionic amino acids via the mammary tissue high affinity,
Na-dependent anionic amino acid carrier operating in the exchange mode. Glutathione was able to trans-accelerate D-
aspartate efflux from lactating rat mammary tissue in a fashion which was sensitive to the peptidase inhibitor acivicin. This
suggests that Q-glutamyltranspeptidase hydrolyses glutathione to produce L-glutamate which is subsequently transported via
the high-affinity anionic amino acid carrier. Hydrolysis of peptides followed by uptake of the constituent amino acids may
provide an important source of amino acids for milk protein synthesis. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Free amino acids are the major form in which
amino-N is taken up by lactating mammary tissue.
Accordingly, transport systems for neutral [1^4],
anionic [5,6] and cationic amino acids [7,8] have
been identi¢ed in mammary tissue from a variety
of species. A number of studies, however, have
shown that the uptake of some essential amino acids,
i.e. those which cannot be synthesized within the
gland, is insu⁄cient to account for their output in
milk protein [9,10]. In the goat, for example, it is
apparent that the uptake of L-phenylalanine and L-
histidine falls short of the gland’s requirements for
milk protein production [11] and it has been sug-
gested that the utilization of circulating peptides, as
a source of amino acids for mammary protein syn-
thesis, may account for the shortfall [12]. It appears
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that the mouse mammary gland is also capable of
utilizing peptides as peptide-bound methionine can
be used as a source of methionine for the synthesis
of secreted proteins [13]. However, the mechanism by
which the mammary gland utilizes peptides is not
clear but may involve (a) extracellular hydrolysis fol-
lowed by uptake of the constituent free amino acids,
(b) intact peptide transport followed by intracellular
hydrolysis to free amino acids, or (c) a combination
of both hydrolysis and transport of peptides.
Using the rat as a model, the present study was
designed to examine the mechanism by which the
lactating mammary gland utilizes peptides for milk
protein synthesis. The ¢rst step in the investigation
was to measure the transport of hydrolysis-resistant
peptides by the lactating rat mammary gland. Thus,
we have examined the transport of dipeptides which
have a D-isomer amino acid at the N terminus: this
con¢guration confers resistance to hydrolysis [14].
Secondly, we have sought evidence for the extracel-
lular hydrolysis of peptides followed by uptake of the
free amino acids. To do this we have exploited the
characteristics of a high-a⁄nity, Na-dependent
anionic amino acid transporter which has been
shown to be present in the basolateral aspect of the
rat mammary epithelium [5,6]. It is apparent that the
mammary tissue high a⁄nity anionic amino acid
transporter, in common with that expressed in neuro-
nal cells [15], is capable of operating as an exchanger
as well as a cotransport system [6]; L-glutamate, L-
aspartate and D-aspartate are able to trans-accelerate
D-aspartate e¥ux (a poorly metabolized substrate of
the transporter) from rat mammary tissue. We have
examined the e¡ect of anionic dipeptides on the ef-
£ux of D-aspartate from mammary tissue. The ra-
tionale is that if mammary tissue is able to hydrolyse
the peptides extracellularly (but not if the peptide
remains intact) then the liberated anionic amino
acid should subsequently trans-stimulate D-aspartate
e¥ux from mammary tissue via the high-a⁄nity
anionic amino acid carrier.
2. Methods and materials
2.1. Animals
Lactating Wistar rats suckling between eight and
ten pups and between 9 and 15 days of lactation were
used in this study. The rats were fed on standard rat
chow (Special Diet Services, Cambridge) and allowed
free access to water. The animals were housed at
constant temperature of 17‡C and under conditions
of 12 h light-dark cycles.
2.2. Measurement of dipeptide and amino acid uptake
by the perfused mammary gland
Mammary tissue was perfused according to the
method described in detail by Clegg and Calvert
[16]. Anaesthesia was induced and maintained
throughout the experiment by an intraperitoneal in-
jection of sodium pentobarbitone (40 mg/kg of body
weight). Abdominal/inguinal mammary tissue was
perfused via the super¢cial epigastric vessels. The
perfusates contained (mM) 118 NaCl, 4 KCl, 2
CaCl2, 1 NaH2PO4, 1 MgSO4, 25 NaHCO3 and 10
glucose and were gassed to pH 7.4 with 95% O2/5%
CO2. In addition, all perfusates were supplemented
with bovine serum albumin (5%).
The transport of dipeptides (D-[3H]Phe-L-Glu and
D-[3H]Phe-L-Gln) and amino acids (L-[3H]Glu and L-
[3H]Gln) by the perfused rat mammary gland was
measured using the rapid, paired-tracer dilution tech-
nique originally described by Yudilevich et al. [17] as
modi¢ed by Millar et al. [5]. A mixture containing a
radiolabelled dipeptide or amino acid and
[14C]sucrose was injected close arterially (approx.
60 Wl in 6 2 s) and 20 venous out£ow samples
were collected at 6 s intervals. Venous out£ow sam-
ples (200 Wl) were mixed with 200 Wl of trichloroacet-
ic acid and centrifuged at 13 000Ug for 2 min. Two
hundred microlitres of the resultant supernatants
were prepared for counting by adding 7 ml of Ulti-
magold liquid scintillation cocktail. The fractional
uptake (U) of the dipeptides and amino acids for
each collection period was calculated according to
Eq. 1:
U  13Rt=Ri 1
where Rt is the ratio of radiolabelled dipeptide (or
amino acid)/radiolabelled sucrose in the venous out-
£ow samples at time t and Ri is the ratio of radio-
labelled dipeptide (or amino acid)/radiolabelled su-
crose in the injectate. The clearance (i.e. the volume
of perfusate notionally cleared of radiolabelled di-
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peptide or amino acid) was calculated by multiplying
the perfusate £ow rate (Wl/min/g tissue) by the uptake
for each collection period.
2.3. Measurement of D-aspartate e¥ux from the
perfused mammary gland
Mammary tissue was perfused as described above.
The perfused mammary tissue was loaded with
radiolabelled D-aspartate by perfusing with a bu¡-
er containing (mM) 118 NaCl, 4 KCl, 2 CaCl2,
1 NaH2PO4, 1 MgSO4, 25 NaHCO 3 and 10 glucose
plus 0.2^0.4 WCi/ml of D-[3H]aspartate for approx. 20
min. All perfusates were supplemented with bovine
serum albumin (5% w/v) and gassed to pH 7.4 with
95% O2/5% CO2. Following the loading period, the
mammary gland was perfused with solutions free of
radioisotopes (see ¢gure legends for details of com-
position) and venous out£ow samples were collected
at 2 min intervals. At the end of the perfusion period
the gland was removed and homogenized. Samples of
the homogenate were incubated in distilled water for
at least 16 h in order to leach out the isotope. The
amount of radioactivity associated with the homoge-
nates was used to calculate the amount of isotope
remaining in the tissue at the end of the perfusion.
Venous out£ow and homogenate samples (0.75 ml)
were mixed with 0.75 ml of 10% trichloroacetic acid
and centrifuged at 13 000Ug for 3 min. One millilitre
of the resulting supernatants was prepared for count-
ing by adding 14 ml of Ultimagold liquid scintillation
cocktail. The fractional e¥ux of radiolabelled D-as-
partate e¥ux from the perfused mammary gland was
calculated according to Eq. 2:
Fractional efflux min31  vX=vtX t 2
where vX represents the amount of radiolabelled D-
aspartate released from the tissue in the time interval
vt and Xt is the tissue D-[3H]aspartate content at
time t. The radioactivity associated with the tissue
at any point of the time course was obtained by
summing the counts left in the tissue at the end of
the e¥ux time course with that of the 2 min samples
in reverse order.
2.4. Preparation of mammary tissue explants
Mammary tissue explants were prepared by the
method described by Shennan [18]. Rats were killed
by cervical dislocation and the abdominal mammary
glands were immediately removed and placed in an
ice-cold bu¡er containing (mM) 135 NaCl, 5 KCl,
2 CaCl2, 1 MgSO4, 10 glucose and 20 Tris-MOPS,
pH 7.4. The mammary tissue was ¢nely dissected to
produce explants weighing between 4 and 8 mg.
Care was taken to remove as much connective
tissue as possible during the preparation of the ex-
plants. The tissue explants were repeatedly washed
with bu¡er prior to the start of the e¥ux experi-
ments.
2.5. Measurement of D-aspartate e¥ux from
mammary tissue explants
D-Aspartate e¥ux, using D-[3H]aspartate as tracer,
was assayed at 37‡C according to the method de-
scribed by Shennan [18]. Mammary tissue explants
were loaded with radiolabelled D-aspartate by incu-
bation at 20‡C for 60 min in a bu¡er containing
(mM) 135 NaCl, 5 KCl, 2 CaCl2, 1 MgSO4, 10 glu-
cose and 20 Tris-MOPS, pH 7.4 plus 3^5 WCi/ml D-
[3H]aspartate. Following the loading incubation, the
tissue explants were transferred through a series of
tubes each containing 2 ml of radioactive-free solu-
tions (see ¢gure legends for precise details of compo-
sition) at 2 min intervals. The radioactivity in these
samples was measured. At the end of the e¥ux in-
cubation, the tissue explant was placed in 4 ml of
distilled water (for at least 16 h) in order to leach
out the remaining isotope. The fractional e¥ux for
each collection period was calculated according to
Eq. 2.
2.6. Measurement of taurine e¥ux from mammary
tissue explants
Isolated rat mammary tissue explants, prepared as
described above, were loaded with [3H]taurine by
incubating for 60 min at 20‡C in a medium contain-
ing (mM) 135 NaCl, 5 KCl, 2 CaCl2, 1 MgSO4, 10
glucose and 20 Tris-MOPS, pH 7.4 to which was
added 1^3 WCi ml31 of radiolabelled taurine. The
e¥ux of radiolabelled taurine was assayed at 37‡C
as described for D-aspartate.
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2.7. Materials
D-[3H]Aspartate and [3H]taurine were purchased
from Amersham International (UK). D-[3H]Phe-L-
Glu and D-[3H]Phe-L-Gln were customer synthesized
by Zeneca (Cambridge Research Biochemicals,
Northwich Cheshire, UK). All other chemicals, in-
cluding the peptides, were obtained from Sigma
(UK).
2.8. Statistics
Di¡erences were assessed by Student’s paired t-test
and considered signi¢cant when P6 0.05.
3. Results
3.1. The clearance of D-[3H]Phe-L-Glu and
L-[3H]Glu by the perfused rat mammary gland
Fig. 1 shows the clearance of D-[3H]Phe-L-Glu by
the perfused lactating rat mammary gland measured
using a rapid, paired-tracer dilution technique. For
comparison we also measured the clearance of L-
[3H]Glu. In this set of experiments (and those de-
scribed below for D-[3H]Phe-L-Gln and L-[3H]Gln)
the substrates were present only in the radiolabelled
form: this was to ensure maximal extraction of the
radiotracers by the perfused tissue. It is evident that
the clearance of D-[3H]Phe-L-Glu was markedly lower
than that of L-[3H]Glu. The magnitude and pro¢le of
L-[3H]Glu clearance, which is via a high a⁄nity
anionic amino acid transport system, is similar to
that reported by Millar et al. [5]. To test whether
or not the small clearance of D-[3H]Phe-L-Glu was
via a high a⁄nity peptide transport system we exam-
ined the e¡ect of adding excess unlabelled L-Leu-L-
Ala to the injectate (at 50 mM). It is evident from
Fig. 1 that L-Leu-L-Ala had no e¡ect on the clear-
ance of D-[3H]Phe-L-Glu by the perfused rat mam-
mary epithelium.
3.2. The clearance of D-[3H]Phe-L-Gln and
L-[3H]Gln by the perfused mammary gland
The clearance of D-[3H]Phe-L-Gln, like that of D-
[3H]Phe-L-Glu, by the perfused mammary gland was
Fig. 2. The clearance of D-[3H]Phe-L-Gln and L-[3H]Gln by the
perfused lactating rat mammary gland. The experimental condi-
tions were essentially the same as those described in the legend
of Fig. 1 except that the injectates contained 8.14 WCi/ml of
D-[3H]Phe-L-Gln (¢nal concentration 0.81 WM) or 7.14 WCi/ml
L-[3H]Gln. When required L-Leu-L-Ala was added to the injec-
tate to give a ¢nal concentration of 50 mM. E and a respec-
tively represent D-[3H]Phe-L-Gln uptake without any additions
(i.e. control), with 50 mM L-Leu-L-Ala present (n = 4 þ S.E. for
each condition). L-[3H]Gln uptake (b) is the mean þ S.E. of ¢ve
experiments.
Fig. 1. The clearance of D-[3H]Phe-L-Glu and L-[3H]Glu by the
perfused lactating rat mammary gland. The perfusates con-
tained (mM) 118 NaCl, 4 KCl, 2 CaCl2, 1 NaH2PO4, 1 MgSO4,
10 glucose and 25 NaHCO3 and were gassed to pH 7.4 with
95% O2/5% CO2. The injectates were of similar composition ex-
cept that they contained 16.79^33.58 WCi/ml of D-[3H]Phe-L-Glu
(¢nal concentration 1.66^3.32 WM) or 7.14 WCi/ml of L-[3H]Glu
(¢nal concentration approx. 0.16 WM). When required, L-Leu-L-
Ala was added to the injectate to give a ¢nal concentration of
50 mM. E and a respectively represent D-[3H]Phe-L-Glu uptake
without any additions (i.e. control) and with L-Leu-L-Ala
present (n = 3 þ S.E. for each condition). L-[3H]Glu uptake (b) is
the mean þ S.E. of six experiments.
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low (Fig. 2). It is evident from Fig. 2 that the clear-
ance of D-[3H]Phe-L-Gln was markedly lower than
that of L-[3H]Gln. Unlabelled L-Leu-L-Ala added to
the injectate at a concentration of 50 mM had no
signi¢cant e¡ect on the clearance of D-[3H]Phe-L-
Gln (Fig. 2).
3.3. The e¡ect of dipeptides on D-aspartate e¥ux
from mammary tissue explants
Previous work has shown that the time course of
D-aspartate e¥ux from mammary tissue explants
consists of two components [6]. The fast component
which represents D-aspartate e¥ux from the tissue
extracellular space became insigni¢cant by 20 min.
Consequently, D-aspartate e¥ux was measured for
40 min before the e¡ect of external dipeptides were
tested. The dipeptides we tested were L-Glu-L-Ala, L-
Ala-L-Asp, L-Asp-Gly, Gly-L-Asp, L-Asp-L-Ala, Gly-
L-Glu, D-Phe-L-Glu and L-Leu-L-Ala. All of the pep-
tides, with the exception of L-Leu-L-Ala, contained
either a glutamate or an aspartate residue. Table 1
shows the e¡ect of these peptides, added to the in-
cubation medium to give a ¢nal concentration of 500
WM, on the fractional e¥ux of D-aspartate. Shown
for comparison is the e¡ect of free L-glutamate and
L-aspartate (both tested at 500 WM) on D-aspartate
e¥ux. It is evident that L-Glu-L-Ala was the most
e¡ective dipeptide tested. Indeed, L-Glu-L-Ala was
75% as e¡ective as free L-glutamate in trans-acceler-
Fig. 3. The dose dependence of L-Glu-L-Ala stimulation of D-as-
partate e¥ux from rat mammary tissue explants. D-Aspartate
e¥ux was ¢rst measured (for 40 min) into a medium containing
(mM) 135 NaCl, 5 KCl, 2 CaCl2, 1 MgSO4, 10 glucose and 20
Tris-MOPS, pH 7.4 followed by one of similar composition
(for 20 min) except that it contained 50 WM (F), 200 WM (a) or
500 WM (b) L-Glu-L-Ala. The results shown are the means þ
S.E.M. of ¢ve experiments when L-Glu-L-Ala was used at 50
WM and 100 WM and seven experiments when L-Glu-L-Ala was
used at 500 WM.
Table 1
The e¡ect of dipeptides on the e¥ux of D-aspartate from lactating rat mammary tissue explants
Dipeptide n Fractional e¥ux (min31) % increase t P
3Peptide +Peptide
L-Glu-L-Ala 7 0.0082 þ 0.0011 0.0336 þ 0.0022 310 4 6 0.001
L-Ala-L-Asp 6 0.0095 þ 0.0019 0.0333 þ 0.0054 251 6 6 0.01
L-Asp-L-Ala 9 0.0065 þ 0.0009 0.0240 þ 0.0036 269 4 6 0.001
L-Asp-Gly 6 0.0060 þ 0.0011 0.0214 þ 0.0030 257 6 6 0.01
Gly-L-Asp 8 0.0070 þ 0.0008 0.0101 þ 0.0012 44 8 6 0.05
Gly-L-Glu 3 0.0062 þ 0.0020 0.0115 þ 0.0026 86 4 6 0.02
L-Leu-L-Ala 4 0.0101 þ 0.0022 0.0095 þ 0.0018 ^ ^ ^
D-Phe-L-Glu 3 0.0080 þ 0.0004 0.0082 þ 0.0006 ^ ^ ^
L-Glu 4 0.0070 þ 0.0009 0.0351 þ 0.0013 401 4 6 0.001
L-Asp 4 0.0086 þ 0.0008 0.0415 þ 0.0032 383 4 6 0.01
D-Aspartate e¥ux was ¢rst measured (for 40 min) into a bu¡er containing (mM) 135 NaCl, 4 KCl, 2 CaCl2, 1 MgSO4, 10 glucose
and Tris-MOPS, pH 7.4 followed by one of similar composition (for 20 min) except that it contained a dipeptide or an anionic amino
acid (at 500 WM). The fractional e¥uxes ( þ S.E.M.) shown are those just prior to the addition of the peptide (3peptide) and those at
the peak response (+peptide). ‘t’ represents the time (min) taken to reach the peak response following the addition of the peptide or
amino acid and ‘n’ is the number of experiments performed with each peptide or amino acid. The L-Asp data are taken from Miller
et al. [6].
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ating D-aspartate e¥ux with respect to both the size
and latency of stimulation. Fig. 3 shows that L-Glu-
L-Ala stimulated D-aspartate e¥ux from rat mam-
mary tissue explants in a concentration-dependent
manner. The next most potent peptides tested were
L-Ala-L-Asp, L-Asp-L-Ala and L-Asp-Gly (Table 1).
On the other hand, Gly-L-Asp and Gly-L-Glu were
relatively weak stimulators of D-aspartate e¥ux. In
addition, the non-hydrolysable peptide D-Phe-L-Glu
was without e¡ect on D-aspartate e¥ux. Similarly, L-
Leu-L-Ala, the only neutral dipeptide tested, had no
signi¢cant e¡ect on D-aspartate e¥ux from mam-
mary tissue explants (Table 1).
We wanted to rule out the possibility that the di-
peptides were increasing D-aspartate e¥ux from
mammary tissue explants as a consequence of cell
lysis. Therefore, we examined the e¡ect of L-Glu-L-
Ala on the fractional release of radiolabelled taurine.
L-Glu-L-Ala, tested at a concentration of 500 WM,
had no e¡ect on the fractional e¥ux of taurine (re-
sults not shown) con¢rming that the e¡ects of the
stimulatory peptides on D-aspartate transport are
speci¢c.
3.4. The e¡ect of L-Glu-L-Ala and L-Glu on
D-aspartate e¥ux from the perfused
mammary gland
We also examined the e¡ect L-Glu-L-Ala on the
e¥ux of D-aspartate from the perfused lactating rat
mammary gland. For comparison, we also studied
the e¡ect of L-Glu on D-Asp e¥ux. In this set of
experiments the gland was initially perfused with
control bu¡er until the fractional e¥ux of D-aspar-
tate had reached a steady state. The release of radio-
labelled D-aspartate was relatively large for the initial
period of the washout (results not shown): this was a
consequence of D-aspartate e¥ux from the tissue ex-
tracellular space. However, this component was min-
imal by 16 min. D-Aspartate e¥ux was measured for
40 min prior to testing the e¡ect of L-Glu-L-Ala and
L-Glu. It is evident from Fig. 4 that addition of L-
Glu-L-Ala to the perfusate trans-stimulated D-aspar-
tate release from the perfused rat mammary gland in
a concentration-dependent fashion. The fractional re-
lease of D-aspartate e¥ux (min31) was increased
(trough-to-peak) from 0.0022 þ 0.0005 to 0.0236 þ
0.0029 min31 (n = 5, P6 0.002) by 500 WM L-Glu-
L-Ala and from 0.0017 þ 0.003 to 0.0066 þ 0.0009
Fig. 5. The e¡ect of glutathione on D-aspartate e¥ux from
mammary tissue explants in the absence (E) and presence (b) of
acivicin. D-Aspartate e¥ux was ¢rst measured into a bu¡er con-
taining (mM) 135 NaCl, 4 KCl, 2 CaCl2, 1 MgSO4, 10 glucose
and 20 Tris-MOPS, pH 7.4 followed by one of similar composi-
tion except that it contained 500 WM glutathione. When re-
quired, acivicin was added to the incubation bu¡er to give a
concentration of 1 mM. The results shown are the means
( þ S.E.) of eight and four experiments in the absence and pres-
ence of acivicin respectively.
Fig. 4. The e¡ect of L-Glu-L-Ala on the fractional release of
D-aspartate from the perfused lactating rat mammary gland.
The gland was initially perfused with a bu¡er containing (mM)
118 NaCl, 4 KCl, 2 CaCl2, 1 KH2PO4, 1 MgSO4, 125
NaHCO3, and 10 glucose (supplemented with BSA (5%) and
gassed to pH 7.4 with 95% O2/5% CO2) followed by one of
similar composition except that it contained 100 WM (F) or
500 WM (b) L-Glu-L-Ala. The results shown are means of ¢ve
and three experiments respectively when 500 WM and 100 WM
L-Glu-L-Ala was used. Error bars are shown by the vertical
lines unless they fall within the size of the symbols.
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min31 (n = 3, P6 0.02) by 100 WM L-Glu-L-Ala. The
fractional e¥ux of D-Asp (min31) was stimulated
from 0.0015 þ 0.0002 to 0.0383 þ 0.0086 min31
(n = 4, P6 0.05) by 500 WM L-Glu.
3.5. The e¡ect of glutathione on D-aspartate
e¥ux from mammary tissue
The tripeptide glutathione (Q-glutamyl-cysteinyl-
glycine), the most abundant oligopeptide in the
body, is a potential source of L-glutamate for the
lactating mammary gland [19]. Therefore, we tested
the e¡ect of glutathione on the e¥ux of D-aspartate
from rat mammary tissue explants and the perfused
lactating rat mammary gland. Fig. 5 illustrates that
glutathione at a concentration of 500 WM markedly
stimulated D-aspartate e¥ux from mammary tissue
explants; the tripeptide increased the fractional e¥ux
(trough-to-peak) from 0.0080 þ 0.0009 min31 to
0.0242 þ 0.0027 min31 (n=8; P6 0.001). We found
that the e¡ect of glutathione on D-aspartate e¥ux
was inhibited by acivicin (1 mM), an inhibitor of Q-
glutamyltranspeptidase in lactating rat mammary tis-
sue [20]. In contrast, acivicin (1 mM) did not inhibit
the e¡ect of 500 WM L-Glu on D-aspartate e¥ux from
mammary tissue explants suggesting that the e¡ect of
acivicin on Q-glutamyltranspeptidase activity is rela-
tively speci¢c (results not shown). Glutathione (at
500 WM) also stimulated D-aspartate release from
the perfused mammary gland; the fractional e¥ux
was increased (trough-to-peak) from 0.0017 þ 0.0001
min31 to 0.0046 þ 0.0004 min31 (n = 3, P6 0.05).
4. Discussion
4.1. Transport of non-hydrolysable peptides by the
perfused mammary gland
The ¢rst step in the investigation demonstrated
that the clearance of two hydrolysis-resistant dipep-
tides, namely D-[3H]Phe-L-Glu and D-[3H]Phe-L-Gln
which are substrates of epithelial peptide transporters
(e.g. see [21,22]), by the perfused lactating mammary
gland was very low even under conditions designed
to maximize uptake of the radiolabelled compounds.
On the other hand, the clearance of two of the con-
stituent amino acids (L-Glu and L-Gln) was high sug-
gesting that the uptake of free amino acids by the
lactating mammary gland is quantitatively more im-
portant than that of intact dipeptides.
The fact remains, however, that there was a small,
albeit signi¢cant uptake of the non-hydrolysable pep-
tides by the basolateral membranes of the lactating
rat mammary epithelium. The question is what is the
nature of the pathway responsible for this measura-
ble uptake of the dipeptides? The clearance of both
peptides was not signi¢cantly inhibited by excess un-
labelled neutral dipeptide suggesting that the small
clearances cannot be attributed to uptake via a
high a⁄nity peptide transport system such as
PepT1 or PepT2 [23,24]. These transporters, which
are proton not sodium linked, are expressed in the
apical membrane of certain epithelia (e.g. proximal
tubule, small intestine); the processes subserving pep-
tide transport across the basolateral membrane of
these tissues, as in the mammary gland, remain un-
known. In view of these ¢ndings it appears that di-
peptide uptake by the lactating rat mammary gland
is the result of transport via a low a⁄nity pathway
(see [25]); experimentally this will be di⁄cult to dis-
tinguish kinetically from di¡usion.
4.2. Extracellular hydrolysis of dipeptides by the
mammary gland
The results from the second part of the study
clearly show that the mammary gland is capable of
hydrolysing dipeptides extracellularly. Thus, anionic
dipeptides are capable of trans-stimulating D-aspar-
tate e¥ux from lactating rat mammary tissue. Ac-
cording to the model depicted in Fig. 6 (using L-
Fig. 6. Proposed scheme of the extracellular hydrolysis of
L-Glu-L-Ala with the subsequent uptake of L-glutamate via the
high a⁄nity, Na-dependent anionic amino acid carrier.
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Glu-L-Ala as an example), we believe that the mam-
mary gland rapidly hydrolyses the dipeptides fol-
lowed by uptake of free anionic amino acids via
the high a⁄nity anionic amino acid transporter
[5,6]. It appears that the mammary gland has a large
capacity to hydrolyse dipeptides. This is based on the
¢nding that L-Glu-L-Ala was 75% as e¡ective as free
L-glutamate in stimulating D-aspartate e¥ux from
tissue explants. Moreover, the results strongly sug-
gest that the site of hydrolysis is extracellular;
anionic amino acids must be at the trans aspect of
the membrane in order to stimulate D-aspartate e¥ux
via the anionic amino acid transporter. If the pep-
tides were being hydrolysed intracellularly, D-aspar-
tate e¥ux would have been inhibited as a conse-
quence of competition between the liberated
anionic amino acids and D-aspartate for a binding
site at the internal face of the anionic amino acid
transporter. Furthermore, the ¢nding that certain di-
peptides were capable of increasing D-aspartate e¥ux
from the perfused mammary gland suggests that the
locus of hydrolysis is at the blood-facing (i.e. baso-
lateral) aspect of the mammary epithelium. This is
based on the reasonable assumption that the per-
fused gland provides a measure of transport across
the blood-facing aspect of the mammary epithelium.
It is possible that the peptides were also hydrolysed
by endothelial cells. However, the ¢nding that
anionic dipeptides stimulated D-aspartate e¥ux
from mammary tissue explants, an experimental
preparation in which the vast majority of the surface
area exposed to the incubation medium is that of the
secretory cells (and not the endothelium), suggests
that the peptides are hydrolysed by the basolateral
membranes of the acinar cells.
Tissue utilization of peptides is not a new concept.
There are many studies relating to the use of peptides
in human parenteral nutrition which have shown
that infused or injected peptides disappear rapidly
from the circulation and, since they do not appear
in urine, it has been inferred that the peptides are
hydrolysed in vivo, with the constituent amino acids
entering the free amino acid pool [26^28]. Indeed,
direct incorporation into milk casein of leucine and
phenylalanine derived from intravascularly infused
Gly-L-[13C]Phe and Gly-L-[13C]Leu has been demon-
strated in goats [12]. In that study, however, it was
not clear whether peptides were hydrolysed systemi-
cally or by the mammary gland itself. The present
study is the ¢rst to show direct mammary tissue hy-
drolysis of dipeptides and transport of the constitu-
ent amino acids. Furthermore, given the experimen-
tal conditions, blood or plasma hydrolysis of the
peptides can be ruled out.
Interestingly, not all of the anionic peptides stimu-
lated D-aspartate e¥ux to the same extent. In partic-
ular, D-Phe-L-Glu had no e¡ect on D-aspartate e¥ux
supporting the claim that dipeptides containing a D-
isomer amino acid at the N terminus resist hydroly-
sis. In addition, those peptides which contained gly-
cine at the N terminus were weak at trans-stimulat-
ing D-aspartate release. This is consistent with
previous ¢ndings that peptides with glycine at the
N terminus are more resistant to hydrolysis [26].
4.3. Metabolism of glutathione by the lactating rat
mammary gland
The results show that glutathione is capable of
stimulating D-aspartate e¥ux from the mammary
gland. This suggests that the mammary gland is
able to hydrolyse glutathione and the glutamate res-
idue so released is able to trans-stimulate D-aspartate
via the high a⁄nity anionic amino acid transport
system. It has been previously shown that rat and
bovine mammary tissue expresses relatively high lev-
els of Q-glutamyltranspeptidase, an enzyme which can
catalyse the release of glutamate from glutathione
[29]. The observation that the e¡ect of glutathione
on D-aspartate e¥ux from mammary tissue was in-
hibited by acivicin is consistent with the notion that
Q-glutamyltranspeptidase was responsible for hydro-
lysing glutathione. Glutathione may be an important
physiological source of glutamate (and of cysteine)
for the mammary gland. In this connection Pocius
et al. [20] presented evidence for an arterio-venous
glutathione concentration di¡erence across the mam-
mary gland.
The study reported here does not shed light on the
handling of peptides at the apical face of the mam-
mary epithelium. It does, however, indicate that, in
addition to nutrition, there are questions of relevance
to the mechanisms of drug delivery to the suckling
neonate (e.g. protease inhibitors) which may be ex-
plored using the experimental protocols described
here.
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